AUTOIMMUNITY REVIEWS

Scope & Guideline

Leading the charge in autoimmune disease insights.

Introduction

Explore the comprehensive scope of AUTOIMMUNITY REVIEWS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore AUTOIMMUNITY REVIEWS in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1568-9972
PublisherELSEVIER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2002 to 2024
AbbreviationAUTOIMMUN REV / Autoimmun. Rev.
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

AUTOIMMUNITY REVIEWS serves as a comprehensive platform for the dissemination of research and reviews on autoimmune diseases, focusing on their pathogenesis, clinical manifestations, and therapeutic strategies. The journal emphasizes a multidisciplinary approach, integrating clinical, laboratory, and translational research to advance the understanding and treatment of autoimmune conditions.
  1. Pathogenesis of Autoimmune Diseases:
    The journal publishes studies exploring the underlying mechanisms of autoimmune diseases, including genetic, environmental, and immunological factors that contribute to disease development.
  2. Clinical Management and Treatment Options:
    AUTOIMMUNITY REVIEWS focuses on the latest advancements in treatment strategies, including pharmacological therapies, biologics, and novel therapeutic approaches to manage autoimmune diseases.
  3. Epidemiology and Burden of Disease:
    Research highlighting the global prevalence, incidence, and impact of autoimmune diseases on populations is a key area of interest, providing insights into public health implications.
  4. Biomarkers and Diagnostic Tools:
    The journal emphasizes the identification and validation of biomarkers for better diagnosis, prognosis, and treatment response monitoring in autoimmune diseases.
  5. Interdisciplinary Approaches:
    Articles often integrate insights from various fields such as immunology, rheumatology, nephrology, and neurology, reflecting the complex nature of autoimmune disorders.
In recent years, AUTOIMMUNITY REVIEWS has embraced several emerging themes that reflect the changing landscape of autoimmune research. These trends indicate a growing interest in innovative therapies, interdisciplinary approaches, and the integration of technology in understanding autoimmune diseases.
  1. Precision Medicine in Autoimmunity:
    Research aimed at tailoring treatments based on individual patient characteristics, including genetic and environmental factors, is gaining traction, highlighting the shift towards personalized approaches in managing autoimmune diseases.
  2. Role of Microbiome in Autoimmunity:
    Studies investigating the influence of gut microbiota on autoimmune disease development and progression have increased, emphasizing the connection between microbiome health and immune regulation.
  3. Artificial Intelligence and Machine Learning Applications:
    The application of AI and machine learning in diagnosing and predicting outcomes in autoimmune diseases is on the rise, showcasing innovative approaches to enhance patient care.
  4. Impact of COVID-19 on Autoimmune Conditions:
    Research exploring the effects of COVID-19 on autoimmune disease incidence, exacerbation, and management has surged, reflecting the pandemic's profound influence on healthcare and autoimmune research.
  5. Environmental Triggers and Autoimmunity:
    There is an increasing focus on understanding the role of environmental factors, such as chemical exposures and lifestyle changes, in triggering or exacerbating autoimmune diseases.

Declining or Waning

While AUTOIMMUNITY REVIEWS continues to thrive in several domains, certain themes have seen a decline in prominence based on recent publications. This shift may reflect evolving research priorities or saturation in specific areas.
  1. Traditional Autoantibody Testing:
    Research focusing solely on traditional autoantibody testing methods has decreased as newer diagnostic technologies and biomarkers gain more attention for their potential in precision medicine.
  2. Basic Science without Clinical Relevance:
    Papers that delve into purely basic science without a clear connection to clinical implications or translational research appear to be less frequent, indicating a shift towards more clinically applicable research.
  3. Single-Disease Focus Studies:
    There is a noticeable decline in publications that focus exclusively on single autoimmune diseases, as the trend moves towards understanding comorbidities and overlaps among various autoimmune conditions.

Similar Journals

JOURNAL OF IMMUNOLOGY

Driving Discoveries in Immune Health
Publisher: AMER ASSOC IMMUNOLOGISTSISSN: 0022-1767Frequency: 24 issues/year

Welcome to the JOURNAL OF IMMUNOLOGY, a prestigious publication associated with the American Association of Immunologists and dedicated to advancing the field of immunology. With a rich history dating back to 1945, this journal is renowned for its high-impact research, evident in its notable 2023 Q1 rankings in both Immunology and Allergy, as well as its strong positions in Scopus rankings—Rank #68 in Immunology and Allergy and Rank #79 in Immunology and Microbiology. Although it operates on a subscription basis, its commitment to publishing cutting-edge studies ensures that it remains a vital resource for scientists, healthcare professionals, and students alike. As the journal continues to pave the way for innovative research and breakthroughs in immunological science, it facilitates a platform for dialogue and discovery among researchers and practitioners across the globe.

Journal of Translational Medicine

Bridging Discovery and Healing.
Publisher: BMCISSN: Frequency: 1 issue/year

Journal of Translational Medicine, published by BMC in the United Kingdom, stands at the forefront of biomedical research, bridging the gap between laboratory discoveries and clinical applications. Established in 2003 as an Open Access journal, it has garnered significant recognition, achieving a Q1 quartile ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023. With an impressive Scopus rank of 38 out of 636 in General Medicine and 33 out of 221 in General Biochemistry, Genetics and Molecular Biology, the journal is committed to disseminating high-quality, peer-reviewed research that impacts healthcare and informs clinical practices. By facilitating free access to groundbreaking studies, the Journal of Translational Medicine aims to enhance collaboration among researchers, professionals, and students in the scientific community, fostering advancements in translational research well into the future.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Advancing the Frontiers of Allergy and Immunology
Publisher: CODON PUBLICATIONSISSN: 0301-0546Frequency: 6 issues/year

ALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.

Expert Review of Clinical Immunology

Bridging research and practice in immunology.
Publisher: TAYLOR & FRANCIS LTDISSN: 1744-666XFrequency: 12 issues/year

Expert Review of Clinical Immunology is a prestigious peer-reviewed journal published by Taylor & Francis Ltd, dedicated to advancing the field of immunology, with a particular focus on clinical applications and therapeutic developments. With an ISSN of 1744-666X and an E-ISSN of 1744-8409, this journal has made a significant impact in the scientific community, evidenced by its Q2 ranking in both Immunology and Allergy for 2023, as well as solid placements in Scopus ranks (73/233 and 87/236 in their respective categories). Operating from the United Kingdom, the journal publishes comprehensive reviews designed to keep researchers, clinicians, and students updated on cutting-edge advancements and trends in immunology. Although it is not an open-access journal, its high impact factor and rigorous editorial standards reinforce its relevance and importance in providing high-quality, evidence-based information. As we progress towards 2024, Expert Review of Clinical Immunology remains a vital resource for anyone involved in the immunological sciences, facilitating knowledge exchange and fostering innovative research within this critical area of medicine.

EUROPEAN JOURNAL OF IMMUNOLOGY

Championing Innovative Insights in Immunology
Publisher: WILEYISSN: 0014-2980Frequency: 12 issues/year

Welcome to the European Journal of Immunology, a premier peer-reviewed journal dedicated to advancing the field of immunology and allergy research. Established in 1971 and published by Wiley, this esteemed journal has been consistently ranked in the top quartile (Q1) across its categories, highlighting its significant impact within the scientific community. With an impressive Scopus ranking, the journal occupies the 64th position in Immunology and Allergy and the 74th in the broader sector of Immunology and Microbiology, demonstrating its vital role in driving innovation and knowledge in immunological studies. The European Journal of Immunology publishes high-quality original research, comprehensive reviews, and insightful commentary, making it an indispensable resource for researchers, healthcare professionals, and students dedicated to understanding the complexities of the immune system. Although not an open-access journal, it offers various subscription options to ensure that institutions and individuals can access pivotal research that shapes the future of immunology.

Case Reports in Immunology

Bridging Knowledge Gaps in Immunology Through Real Cases
Publisher: HINDAWI LTDISSN: 2090-6609Frequency:

Case Reports in Immunology, published by HINDAWI LTD, is an esteemed open-access journal that has been contributing to the field of immunology since its launch in 2011. With both ISSN 2090-6609 and E-ISSN 2090-6617, the journal provides a platform for researchers to publish detailed case reports that explore diverse immunological conditions and novel treatment approaches. This journal is crucial for clinicians, researchers, and students alike, seeking to broaden their understanding of immunology's practical applications and advances. As of 2023, it holds a Q3 ranking in Immunology and Q2 in Immunology and Allergy, reflecting its growing relevance and contribution to the field. Additionally, it is indexed in Scopus, where it ranks #178 in Immunology and Allergy and #192 in Immunology and Microbiology, enhancing its visibility and impact. With a comprehensive accessibility model, the journal is dedicated to disseminating knowledge widely and enriching discussions in immunological research.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Advancing Immunology and Pharmacology for a Healthier Tomorrow.
Publisher: SAGE PUBLICATIONS INCISSN: 0394-6320Frequency: 1 issue/year

Welcome to the International Journal of Immunopathology and Pharmacology, a premier publication dedicated to advancing the fields of immunology and pharmacology. Published by SAGE Publications Inc., this Open Access journal has been a vital resource since its inception in 1989, providing an expansive platform for innovative research and comprehensive reviews until 2024. With a strong focus on the mechanisms of immune responses and therapeutic developments, our journal stands out with a 2023 impact factor reflected in its Q3 ranking in Immunology and Allergy, and a Q2 ranking in Pharmacology. The journal's Scopus rankings highlight its significance, ranking #174 in Pharmacology, #141 in Medicine, and #156 in Immunology, all affirming its role in contributing to the broader scientific community. Through rigorous peer review and a commitment to high-quality research, the International Journal of Immunopathology and Pharmacology continues to be an essential resource for scientists, healthcare professionals, and students striving to enhance their knowledge and understanding in these critical fields.

AUTOIMMUNITY

Illuminating the pathways of immune disorders.
Publisher: TAYLOR & FRANCIS LTDISSN: 0891-6934Frequency: 8 issues/year

AUTOIMMUNITY, published by Taylor & Francis Ltd, is an influential journal dedicated to advancing the understanding of autoimmune diseases through rigorous research and scholarly discourse. With an ISSN of 0891-6934 and an E-ISSN of 1607-842X, this journal serves as a key resource for immunologists, medical professionals, and students engaged in investigating the complex mechanisms underpinning autoimmunity. Operating from the United Kingdom, it offers valuable insights into immunological and allergic phenomena, achieving respectable Scopus rankings in both Immunology and Allergy (106/233, Q3) and Immunology and Microbiology (125/236, Q2). Covering a broad spectrum of topics since its inception in 1988, AUTOIMMUNITY encourages the dissemination of innovative research findings and aims to enhance collaborative efforts within the field. While it currently adopts a conventional access model, the journal's commitment to quality and excellence positions it as a vital platform for those looking to engage with cutting-edge research in immunology.

American Journal of Clinical and Experimental Immunology

Exploring the Frontiers of Clinical and Experimental Immunology
Publisher: E-CENTURY PUBLISHING CORPISSN: Frequency: 6 issues/year

Welcome to the American Journal of Clinical and Experimental Immunology, a premier publication dedicated to advancing the fields of clinical and experimental immunology. Published by E-CENTURY PUBLISHING CORP, this journal provides a platform for groundbreaking research, case studies, and comprehensive reviews that contribute to our understanding of the immune system and its implications for health and disease. With a focus on disseminating innovative findings and enhancing the dialogue among researchers, practitioners, and students, the journal aims to bridge the gap between laboratory discoveries and clinical applications. Although specific metrics such as the impact factor and Scopus ranks are currently not provided, the journal is committed to maintaining high standards of scholarly publishing and fostering open access to vital research. Located in Madison, WI, and available online via its E-ISSN 2164-7712, this journal is a valuable resource for those wishing to explore the intricacies of immunological research and its applications in clinical practice.

IMMUNOLOGY LETTERS

Elevating Immunology: Where Research Meets Practice
Publisher: ELSEVIERISSN: 0165-2478Frequency: 12 issues/year

IMMUOLOGY LETTERS, published by Elsevier, is a distinguished journal in the field of immunology, focusing on the latest advancements and findings that significantly influence immunological research and clinical applications. Established in 1979, the journal has evolved to cater to a global readership, featuring high-quality peer-reviewed articles across a diverse spectrum of topics related to immunity and allergic responses. With an impressive Q2 category ranking in both Immunology and Allergy as of 2023, it holds a strong position within the scientific community, evidenced by its commendable Scopus rankings (Rank #71/233 in Medicine - Immunology and Allergy and Rank #85/236 in Immunology and Microbiology - Immunology). While primarily subscription-based, the journal aims to foster knowledge dissemination that encourages collaboration among researchers and practitioners alike, making significant contributions to the understanding of immune mechanisms. The journal is integral for educators, students, and professionals aiming to stay abreast of current trends and breakthroughs in the immune system's intricate functions.